2O9 vs AZN: Side-by-Side Comparison
Compare RENALYTIX PLC LS-0025 (2O9) and Astrazeneca plc (AZN) side by side: market cap EUR 8.74M vs USD 302.65B. Financials, growth and model signals on Bullrun.
| Metric | 2O9 | AZN |
|---|---|---|
| Company | RENALYTIX PLC LS-0025 | Astrazeneca plc |
| Country / Exchange | United Kingdom · F | United Kingdom · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Drug Manufacturers-General |
| Market cap | EUR 8.74M | USD 302.65B |
| P/E ratio | — | 58.6 |
| Dividend yield | — | 1.63% |
| Valuation model | — | 29.8% overvalued |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |